This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200701-057OCv1 177/3/348    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bennett, D. E. Articles by Castro, K. G. Search for Related Content PubMed PubMed Citation Articles by Bennett, D. E. Articles by Castro, K. G.

Prevalence of Tuberculosis Infection in the United States Population

The National Health and Nutrition Examination Survey, 1999–2000

Diane E. Bennett¹, Jeanne M. Courval², Ida Onorato^1,, Tracy Agerton¹, Judy D. Gibson¹, Lauren Lambert¹, Geraldine M. McQuillan³, Brenda Lewis³, Thomas R. Navin¹ and Kenneth G. Castro¹

¹ Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, Georgia; ² RTI International, Atlanta, Georgia; and ³ Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, Maryland

Correspondence and requests for reprints should be addressed to Thomas R. Navin, M.D., 1600 Clifton Rd., Mailstop E-10, Atlanta, GA 30333. E-mail: tnavin{at}cdc.gov

Rationale: The goal for tuberculosis (TB) elimination in the United States is a TB disease incidence of less than 1 per million U.S. population by 2010, which requires that the latent TB infection (LTBI) prevalence be less than 1% and decreasing.

Objectives: To estimate the prevalence of LTBI in the U.S. population.

Methods and Measurements: Interviews and medical examinations, including tuberculin skin testing (TST), of 7,386 individuals were conducted in 1999–2000 as part of the National Health and Nutrition Examination Survey (NHANES), a nationally representative sample of the civilian, noninstitutionalized U.S. population. LTBI was defined as a TST measurement of 10 mm. Associations of age, race/ethnicity, sex, poverty, and birthplace were assessed. Results among the 24- to 74-year-old subgroup were compared with NHANES 1971–1972 data.

Measurements and Main Results: Estimated LTBI prevalence was 4.2%; an estimated 11,213,000 individuals had LTBI. Among 25- to 74-year-olds, prevalence decreased from 14.3% in 1971–1972 to 5.7% in 1999–2000. Higher prevalences were seen in the foreign born (18.7%), non-Hispanic blacks/African Americans (7.0%), Mexican Americans (9.4%), and individuals living in poverty (6.1%). A total of 63% of LTBI was among the foreign born. Among the U.S. born, after adjusting for confounding factors, LTBI was associated with non-Hispanic African-American race/ethnicity, Mexican American ethnicity, and poverty. A total of 25.5% of persons with LTBI had been previously diagnosed as having LTBI or TB, and only 13.2% had been prescribed treatment.

Conclusions: In addition to basic TB control measures, elimination strategies should include targeted evaluation and treatment of individuals in high-prevalence groups, as well as enhanced support for global TB prevention and control.

Key Words: tuberculosis infection • tuberculin test • epidemiology • United States

AT A GLANCE COMMENTARY Scientific Knowledge on the Subject Estimated national prevalence of latent tuberculosis infection in the United States decreased from 14.3% in the early 1970s to 5.7% in 1999–2000 among persons 24–74 years of age. Rates of active TB disease also decreased from 15.8 to 5.6 per 100,000 during the same period in the U.S. population as a whole, but both of these reported decreases mask continuing high rates among important groups such as the foreign-born population and U.S.-born ethnic minorities. What This Study Adds to the Field Based on a representative national survey, latent TB infection prevalence in the United States was 4.2% in 1999–2000, with significantly higher rates in some subgroups. Only 25.5% of persons with latent TB infection had been diagnosed, and only 13.2% had been prescribed treatment.

 

This article has been cited by other articles:

				W. W. Yew and C. C. Leung Update in Tuberculosis 2008 Am. J. Respir. Crit. Care Med., March 1, 2009; 179(5): 337 - 343. [Full Text] [PDF]

				M. N. Lobato, J. A. Jereb, and K. G. Castro Do We Have Evidence for Policy Changes in the Treatment of Children With Latent Tuberculosis Infection? Pediatrics, March 1, 2009; 123(3): 902 - 903. [Full Text] [PDF]

				P. Kahn Evaluation of a Tuberculosis Skin Testing Program The Journal of School Nursing, February 1, 2009; 25(1): 48 - 54. [Abstract] [Full Text] [PDF]

				H. M. Blumberg Needed: New and Better Tools to Combat Latent Tuberculosis Infection Ann Intern Med, November 18, 2008; 149(10): 761 - 763. [Full Text] [PDF]

				T. R. Navin, J. M. Courval, J. E. Becerra, D. E. Bennett, and K. G. Castro What Can the NHANES Data Tell Us about the Tuberculin Skin Test and the Risk for Active Tuberculosis? Am. J. Respir. Crit. Care Med., October 15, 2008; 178(8): 884 - 884. [Full Text] [PDF]

				R. Belknap, K. Wall, and R. Reves What Can the NHANES Data Tell Us about the Tuberculin Skin Test and the Risk for Active Tuberculosis? Am. J. Respir. Crit. Care Med., October 15, 2008; 178(8): 883 - 884. [Full Text] [PDF]

				H. L. Rieder Estimating the Prevalence of Tuberculosis Infection in the United States Population Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 651 - 651. [Full Text] [PDF]

				K. Khan, T. R. Navin, J. M. Courval, A. Bierman, D. E. Bennett, K. G. Castro, and M. Gardam Decline in Prevalence of Latent Tuberculosis Infection: Is the Waning of Tuberculin Reaction a Factor? Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 652 - 653. [Full Text] [PDF]

				C. C. Leung and W. W. Yew Decline in Prevalence of Latent Tuberculosis Infection: Is the Waning of Tuberculin Reaction a Factor? Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 651 - 652. [Full Text] [PDF]

				K. P. Cain, S. R. Benoit, C. A. Winston, and W. R. Mac Kenzie Tuberculosis Among Foreign-Born Persons in the United States JAMA, July 23, 2008; 300(4): 405 - 412. [Abstract] [Full Text] [PDF]

				C. C. Leung, W. C. Bailey, and W. W. Yew Screening Contacts of Tuberculosis: Overcoming Obstacles with an Old Tool Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 939 - 940. [Full Text] [PDF]

				Elimination of TB in the U.S. Not Currently Achievable Journal Watch Infectious Diseases, February 20, 2008; 2008(220): 6 - 6. [Full Text]